Page 273 - Read Online
P. 273

Vasefi et al. Vessel Plus 2020;4:24  I  http://dx.doi.org/10.20517/2574-1209.2020.16                                                  Page 9 of 11

                   subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J Biol Chem 2000;275:5228-37.
               39.  Krizman-Genda E, Gonzalez MI, Zelenaia O, Robinson MB. Evidence that Akt mediates platelet-derived growth factor-dependent
                   increases in activity and surface expression of the neuronal glutamate transporter, EAAC1. Neuropharmacology 2005;49:872-82.
               40.  Iihara K, Hashimoto N, Tsukahara T, Sakata M, Yanamoto H, et al. Platelet-derived growth factor-BB, but not -AA, prevents delayed
                   neuronal death after forebrain ischemia in rats. J Cereb Blood Flow Metab 1997;17:1097-106.
               41.  Kawabe T, Wen TC, Matsuda S, Ishihara K, Otsuda H, et al. Platelet-derived growth factor prevents ischemia-induced neuronal injuries in
                   vivo. Neurosci Res 1997;29:335-43.
               42.  Sakata M, Yanamoto H, Hashimoto N, Iihara K, Tsukahara T, et al. Induction of infarct tolerance by platelet-derived growth factor against
                   reversible focal ischemia. Brain Res 1998;784:250-5.
               43.  Egawa-Tsuzuki T, Ohno M, Tanaka N, Takeuchi Y, Uramoto H, et al. The PDGF B-chain is involved in the ontogenic susceptibility of the
                   developing rat brain to NMDA toxicity. Exp Neurol 2004;186:89-98.
               44.  Iihara K, Sasahara M, Hashimoto N, Uemura Y, Kikuchi H, et al. Ischemia induces the expression of the platelet-derived growth factor-B
                   chain in neurons and brain macrophages in vivo. J Cereb Blood Flow Metab 1994;14:818-24.
               45.  Suzuki J, Baba S, Ohno I, Endoh M, Nawata J, et al. Immunohistochemical analysis of platelet-derived growth factor-B expression in
                   myocardial tissues in hypertrophic cardiomyopathy. Cardiovasc Pathol 1999;8:223-31.
               46.  Lee JC, Kim YH, Lee TK, Kim IH, Cho JH, et al. Effects of ischemic preconditioning on PDGF-BB expression in the gerbil hippocampal
                   CA1 region following transient cerebral ischemia. Mol Med Rep 2017;16:1627-34.
               47.  Ohno M, Sasahara M, Narumiya S, Tanaka N, Yamano T, et al. Expression of platelet-derived growth factor B-chain and beta-receptor in
                   hypoxic/ischemic encephalopathy of neonatal rats. Neuroscience 1999;90:643-51.
               48.  Krupinski J, Issa R, Bujny T, Slevin M, Kumar P, et al. A putative role for platelet-derived growth factor in angiogenesis and
                   neuroprotection after ischemic stroke in humans. Stroke 1997;28:564-73.
               49.  Ishii Y, Oya T, Zheng L, Gao Z, Kawaguchi M, et al. Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are
                   vulnerable to injury. J Neurochem 2006;98:588-600.
               50.  Nikolakopoulou AM, Zhao Z, Montagne A, Zlokovic BV. Regional early and progressive loss of brain pericytes but not vascular smooth
                   muscle cells in adult mice with disrupted platelet-derived growth factor receptor-beta signaling. PLoS One 2017;12:e0176225.
               51.  Lewandowski SA, Fredriksson L, Lawrence DA, Eriksson U. Pharmacological targeting of the PDGF-CC signaling pathway for blood-
                   brain barrier restoration in neurological disorders. Pharmacol Ther 2016;167:108-19.
               52.  Shen J, Ishii Y, Xu G, Dang TC, Hamashima T, et al. PDGFR-beta as a positive regulator of tissue repair in a mouse model of focal
                   cerebral ischemia. J Cereb Blood Flow Metab 2012;32:353-67.
               53.  Shibahara T, Ago T, Nakamura K, Tachibana M, Yoshikawa Y, et al. Pericyte-mediated tissue repair through PDGFRbeta promotes peri-
                   infarct astrogliosis, oligodendrogenesis, and functional recovery after acute ischemic stroke. eNeuro 2020;7.
               54.  Shen J, Xu G, Zhu R, Yuan J, Ishii Y, et al. PDGFR-beta restores blood-brain barrier functions in a mouse model of focal cerebral
                   ischemia. J Cereb Blood Flow Metab 2019;39:1501-15.
               55.  Niu F, Yao H, Liao K, Buch S. HIV Tat 101-mediated loss of pericytes at the blood-brain barrier involves PDGF-BB. Ther Targets Neurol
                   Dis 2015;2:e471.
               56.  Niu F, Yao H, Zhang W, Sutliff RL, Buch S. Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived
                   growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders. J Neurosci
                   2014;34:11812-25.
               57.  Miners JS, Schulz I, Love S. Differing associations between Abeta accumulation, hypoperfusion, blood-brain barrier dysfunction
                   and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer’s disease. J Cereb Blood Flow Metab
                   2018;38:103-15.
               58.  Padel T, Ozen I, Boix J, Barbariga M, Gaceb A, et al. Platelet-derived growth factor-BB has neurorestorative effects and modulates the
                   pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson’s disease. Neurobiol Dis 2016;94:95-105.
               59.  Milesi S, Boussadia B, Plaud C, Catteau M, Rousset MC, et al. Redistribution of PDGFRbeta cells and NG2DsRed pericytes at the
                   cerebrovasculature after status epilepticus. Neurobiol Dis 2014;71:151-8.
               60.  Bethel-Brown C, Yao H, Hu G, Buch S. Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant
                   protein 1 in human astrocytes: implications for HIV-associated neuroinflammation. J Neuroinflammation 2012;9:262.
               61.  Jansson D, Scotter EL, Rustenhoven J, Coppieters N, Smyth LC, et al. Interferon-gamma blocks signalling through PDGFRbeta in human
                   brain pericytes. J Neuroinflammation 2016;13:249.
               62.  Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992;256:184-5.
               63.  Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, Meltzer AC, Siao Tick Chong M, et al. Distinct cytokine profiles in human brains
                   resilient to Alzheimer’s pathology. Neurobiol Dis 2019;121:327-37.
               64.  O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 2011;34:185-204.
               65.  Kim C, Jang CH, Bang JH, Jung MW, Joo I, et al. Amyloid precursor protein processing is separately regulated by protein kinase C and
                   tyrosine kinase in human astrocytes. Neurosci Lett 2002;324:185-8.
               66.  Gianni D, Zambrano N, Bimonte M, Minopoli G, Mercken L, et al. Platelet-derived growth factor induces the beta-gamma-secretase-
                   mediated cleavage of Alzheimer’s amyloid precursor protein through a Src-Rac-dependent pathway. J Biol Chem 2003;278:9290-7.
               67.  Zambrano N, Gianni D, Bruni P, Passaro F, Telese F, et al. Fe65 is not involved in the platelet-derived growth factor-induced processing
                   of Alzheimer’s amyloid precursor protein, which activates its caspase-directed cleavage. J Biol Chem 2004;279:16161-9.
               68.  Friedman R, Pellarin R, Caflisch A. Amyloid aggregation on lipid bilayers and its impact on membrane permeability. J Mol Biol
   268   269   270   271   272   273   274   275   276   277   278